@1ncog
Great opinions, just want to clarify one thing.
For a med tech company banking on success of their trials to enter this lucrative sector.
If we don't focus on the results of each of its trials (in this case OSA being the first horse, out of it's gates so to speak), what should the investors / shareholders be focusing on in your opinion?
General discussion, page-11535
-
- There are more pages in this discussion • 8,729 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)